To start with when they listed they only offered 10% of the company in the IPO and asked for $50m+ for that 10% - where as PYC has been washing out the registry ever since growing it 8x larger for less than $20M in total. They have 68 compounds from hits and a number of clinical candidates with 18 pharma partners several of those with multiple deals - they take the compounds further than just discovery hits. While PYC has billions Peptidream have trillions possible. They also have deals were they basically transfer their platform to partners.
PYC Price at posting:
4.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)